These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15359831)

  • 41. Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell.
    Agaugué S; Perrin-Cocon L; André P; Lotteau V
    PLoS One; 2007 Mar; 2(3):e330. PubMed ID: 17389921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
    Liese J; Schleicher U; Bogdan C
    Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dendritic cell maturation and generation of immune responses.
    Lanzavecchia A
    Haematologica; 1999 Jun; 84 Suppl EHA-4():23-5. PubMed ID: 10907459
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: a feedback regulation of Th1 development.
    Skok J; Poudrier J; Gray D
    J Immunol; 1999 Oct; 163(8):4284-91. PubMed ID: 10510367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C core protein - the "core" of immune deception?
    Szabo G; Dolganiuc A
    J Hepatol; 2008 Jan; 48(1):8-11. PubMed ID: 18023495
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanism of HCV persistence].
    Hiroishi K; Ishii S; Imawari M
    Nihon Rinsho; 2011 May; 69 Suppl 4():92-6. PubMed ID: 22096900
    [No Abstract]   [Full Text] [Related]  

  • 48. Modulation of the Natural Killer Cell Compartment during DAAs treatment in Interferon-naïve HCV patients: The type of DAA matters.
    Nicolini LA; Dettori S; Bozzano F; Di Biagio A; De Maria A
    Immunol Lett; 2018 Nov; 203():112-115. PubMed ID: 30144471
    [No Abstract]   [Full Text] [Related]  

  • 49. Do direct acting antivirals cure chronic hepatitis C?
    Jakobsen JC; Nielsen EE; Koretz RL; Gluud C
    BMJ; 2018 May; 361():k1382. PubMed ID: 29748173
    [No Abstract]   [Full Text] [Related]  

  • 50. Dendritic cells star in Vancouver.
    Klechevsky E; Kato H; Sponaas AM
    J Exp Med; 2005 Jul; 202(1):5-10. PubMed ID: 15998786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer cells and hepatitis C: natural killer p46 expression linked to antiviral and antifibrotic activity.
    Heeg M; Thimme R
    Hepatology; 2012 Oct; 56(4):1197-200. PubMed ID: 22610395
    [No Abstract]   [Full Text] [Related]  

  • 52. Immune-related disorders and extrahepatic diseases in chronic HCV infection.
    Sansonno D
    Clin Dev Immunol; 2012; 2012():509309. PubMed ID: 23097672
    [No Abstract]   [Full Text] [Related]  

  • 53. Finding a role for Th17 cells in hepatitis C pathogenesis.
    Bowen DG
    J Gastroenterol Hepatol; 2012 Feb; 27(2):188-91. PubMed ID: 22260280
    [No Abstract]   [Full Text] [Related]  

  • 54. Flow cytometry makes all the difference.
    Pembroke T; Gallimore A; Godkin A
    J Hepatol; 2013 Oct; 59(4):909-10. PubMed ID: 23792877
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to: "Flow cytometry makes all the difference".
    Oliviero B; Mele D; Varchetta S; Mondelli MU
    J Hepatol; 2013 Oct; 59(4):910-1. PubMed ID: 23796476
    [No Abstract]   [Full Text] [Related]  

  • 56. [The factors leading hepatitis C to chronicnization].
    Fan WM; Zhu WF
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):436-8. PubMed ID: 12890353
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 58. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].
    Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM
    Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.